TARA
Protara Therapeutics Inc.
$3.67
+$0.48(+15.05%)
41
Overall
--
Value
41
Tech
--
Quality
Market Cap
$118.45M
Volume
3.09M
52W Range
$1.60 - $10.48
Target Price
$22.17
EPS Estimates Overview
| Current Quarter | $-0.39 | Next Quarter | $-0.42 |
| Current Year | $-1.36 | Next Year | $-1.76 |
| QoQ Growth | -7.7% | YoY Growth | -29.4% |
| 3Y EPS CAGR | +19.8% | Target Price | $22.17 |
| Consensus | Buy | Upside | +504.1% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TARA | $3.67 | +15.0% | 3.09M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Protara Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW